Markets
Dr Reddy’s Lab Q4 Results: Consolidated PAT at ₹959 cr, declares 800% dividend
Pharma giant, Dr Reddy’s Lab posted a consolidated net profit of ₹960.1 crore for the fourth quarter of FY23, rising by multi-fold on a year-on-year basis. Revenue also picked up traction YoY. However, the Q4FY23 performance was feeble on a quarter-on-quarter basis.
The company’s Q4 PAT jumped by 9.9 times or 889.79% from a profit of ₹97 crore in Q4FY23. However, sequentially, the PAT witnessed a decline as against ₹1,243.9 crore in Q3FY23.
Know your inner investor
Do you have the nerves of steel or do you get insomniac over your investments? Let’s define your investment approach.
Take the test
Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint.
Download The Mint News App to get Daily Market Updates.
Download The Mint News App to get Daily Market Updates.
More
Less
